Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Free Cash Flow (2018 - 2025)

Health Catalyst's Free Cash Flow history spans 8 years, with the latest figure at $8.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 285.12% year-over-year to $8.9 million; the TTM value through Dec 2025 reached -$237000.0, down 101.83%, while the annual FY2025 figure was -$237000.0, 101.83% down from the prior year.
  • Free Cash Flow reached $8.9 million in Q4 2025 per HCAT's latest filing, up from -$436000.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $10.2 million in Q1 2024 to a low of -$19.0 million in Q4 2023.
  • Average Free Cash Flow over 5 years is -$4.1 million, with a median of -$4.9 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: tumbled 904.23% in 2021, then surged 285.12% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$10.2 million in 2021, then plummeted by 64.9% to -$16.9 million in 2022, then fell by 12.87% to -$19.0 million in 2023, then soared by 74.6% to -$4.8 million in 2024, then soared by 285.12% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Free Cash Flow are $8.9 million (Q4 2025), -$436000.0 (Q3 2025), and -$8.8 million (Q2 2025).